Approval · Notice of Compliance 3278 · 1997
NORVASC: Notice of Compliance 3278
Issued August 1, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3278
- Date
- August 1, 1997
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for product monograph revision
- Therapeutic class
- Antihypertensive - antianginal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NORVASC | Not yet assigned | — |
Medicinal ingredients
- AMLODIPINE BESYLATE 5 MG per TAB
- AMLODIPINE BESYLATE 10 MG per TAB
- AMLODIPINE BESYLATE 2.5 MG per TAB